Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
technetium Tc 99m tetrofosmin
- Development stage
- Phase 4
- Lead developer
- GE Healthcare
- Modality
- Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
- Administration
- Intravenous
01
Overview
Technetium Tc 99m tetrofosmin, marketed under the brand name Myoview by GE Healthcare, is a radioactive diagnostic agent used in nuclear medicine cardiac imaging. It is a lipophilic cationic small molecule radiopharmaceutical complexed with the radioisotope technetium-99m. Myoview is indicated for myocardial perfusion imaging (MPI) using single-photon emission computed tomography (SPECT) to delineate regions of reversible myocardial ischemia or infarcted myocardium in patients with known or suspected coronary artery disease. The agent is rapidly taken up by viable myocardial tissue via passive diffusion and accumulates within mitochondria, reflecting regional blood flow. It is also used to assess left ventricular function, including ejection fraction and wall motion.
- Brand names
- Myoview
- Other names
- technetium (99mTc) tetrofosmin99mTc-tetrofosminTc-99m tetrofosminTc99m tetrofosminTc 99m tetrofosmin
Beyond the preview
Go deeper on technetium Tc 99m tetrofosmin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on technetium Tc 99m tetrofosmin.